Meghan Meadows-Taylor - Publications

Affiliations: 
2020 University of Memphis, Memphis, TN, United States 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Smeltzer MP, Ray MA, Faris NR, Meadows-Taylor MB, Rugless F, Berryman C, Jackson B, Fehnel C, Pacheco A, McHugh L, Robbins ET, Ward KD, Klesges LM, Osarogiagbon RU. Prospective Comparative Effectiveness Trial of Multidisciplinary Lung Cancer Care Within a Community-Based Health Care System. Jco Oncology Practice. OP2100815. PMID 35609221 DOI: 10.1200/OP.21.00815  0.742
2022 Osarogiagbon RU, Liao W, Faris NR, Meadows-Taylor M, Fehnel C, Lane J, Williams SC, Patel AA, Akinbobola OA, Pacheco A, Epperson A, Luttrell J, McCoy D, McHugh L, Signore R, et al. Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102496. PMID 35258994 DOI: 10.1200/JCO.21.02496  0.749
2022 Meadows-Taylor MB, Faris NR, Smeltzer MP, Ray MA, Fehnel C, Akinbobola O, Ariganjoye F, Patel A, Pacheco A, Mehrotra A, Fox R, Optican R, Tonkin K, Machin J, Wright J, et al. The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer. Chest. PMID 35122751 DOI: 10.1016/j.chest.2022.01.046  0.751
2021 Ray MA, Faris NR, Fehnel C, Derrick A, Smeltzer MP, Meadows-Taylor MB, Ariganjoye F, Pacheco A, Optican R, Tonkin K, Wright J, Fox R, Callahan T, Robbins ET, Walsh W, et al. Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System. Jto Clinical and Research Reports. 2: 100203. PMID 34590046 DOI: 10.1016/j.jtocrr.2021.100203  0.716
2021 Meadows-Taylor M, Ward KD, Chen W, Faris NR, Fehnel C, Ray MA, Ariganjoye F, Berryman C, Houston-Harris C, McHugh LM, Pacheco A, Osarogiagbon RU. Interest in Cessation Treatment Among People Who Smoke in a Community-Based Multidisciplinary Thoracic Oncology Program. Jto Clinical and Research Reports. 2: 100182. PMID 34590029 DOI: 10.1016/j.jtocrr.2021.100182  0.578
2021 Smeltzer MP, Faris NR, Fehnel C, Akinbobola O, Saulsberry A, Meadows-Taylor M, Pacheco A, Ray M, Osarogiagbon RU. Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis. Jto Clinical and Research Reports. 2: 100161. PMID 34590011 DOI: 10.1016/j.jtocrr.2021.100161  0.727
2021 Smeltzer MP, Lee YS, Faris NR, Fehnel C, Akinbobola O, Meadows-Taylor M, Spencer D, Sales E, Okun S, Giampapa C, Anga A, Pacheco A, Ray M, Osarogiagbon RU. Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected Non-small Cell Lung Cancer (NSCLC) in a High Mortality Area of the United States. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34280563 DOI: 10.1016/j.jtho.2021.06.027  0.749
2021 Osarogiagbon RU, Smeltzer MP, Faris NR, Ray MA, Fehnel C, Ojeabulu P, Akinbobola O, Meadows-Taylor M, McHugh LM, Halal AM, Levy P, Sachdev V, Talton R, Wiggins L, Shu XO, et al. Outcomes Following Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33607311 DOI: 10.1016/j.jtho.2020.12.025  0.747
2020 Mathias JG, Nolan VG, Meadows-Taylor M, Robinson LA, Howell KE, Gurney JG, Hankins JS, Wang WC, Estepp JH, Smeltzer MP. A meta-analysis of toxicities related to hydroxycarbamide dosing strategies. Ejhaem. 1: 235-238. PMID 35847723 DOI: 10.1002/jha2.7  0.578
2020 Thomas K, Voros BA, Meadows-Taylor M, Smeltzer MP, Griffin R, Boudreaux JP, Thiagarajan R, Woltering EA, Ramirez RA. Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs). Cancers. 12. PMID 31947598 DOI: 10.3390/cancers12010206  0.654
Show low-probability matches.